incyte corp (INCY:NASDAQ GS)
Richard S. Levy M.D.
Chief Drug Development & Medical Officer and Executive Vice President, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2012
Dr. Richard S. Levy, M.D. has been the Chief Drug Development Officer & Medical Officer and Executive Vice President of Incyte Corporation since January 2009. Dr. Levy served as the Senior Vice President of Drug Development of Incyte Corporation since August 26, 2003. He has over 12 years of experience in the pharmaceutical and biotechnology sectors through his prior positions at Celgene, DuPont Pharmaceuticals and Novartis. Most recently, he served as Vice President ...
Experimental StationPhone: 302-498-6700
Wilmington, Delaware 19880
Board Members Memberships*
The University of Pennsylvania
|Harvey J. Berger M.D.||Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Werner Lanthaler MBA/MPA||Chief Executive Officer|
|€601.0K||Compensation as of Fiscal Year 2012.|